Rx Industry IG Compliance Group Supports FDA Systems Model For Audits
Executive Summary
The "Ad Hoc OIG Compliance Group" will advocate the "systems-based" auditing approach recommended by FDA when it meets with the HHS Inspector General to discuss a pharmaceutical industry compliance policy guidance.
You may also be interested in...
PhRMA Marketing Rule Codification Could Re-Emerge On Capitol Hill
Legislation to codify PhRMA's voluntary marketing guidelines would have a strong chance of passing in 2003, Arnold & Porter Partner John Bentivoglio told the Health Industry Group Purchasing Association annual meeting Feb. 3 in Half Moon Bay, Calif
PhRMA Marketing Rule Codification Could Re-Emerge On Capitol Hill
Legislation to codify PhRMA's voluntary marketing guidelines would have a strong chance of passing in 2003, Arnold & Porter Partner John Bentivoglio told the Health Industry Group Purchasing Association annual meeting Feb. 3 in Half Moon Bay, Calif
Market Share-Based Rebates Are Not Rx Switch Deals, Manufacturers Argue
Drug rebates based on market share and payments to PBMs to disseminate product information are not switching arrangements, a group of 19 manufacturers maintain in comments on the HHS Inspector General's draft compliance guidance
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: